Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2019 | Pages:
90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global antacid market size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market. Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%. Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio. The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited. Further key findings from the report suggest: • In 2017, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population • Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness • Asia Pacific is estimated to be the largest and fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others • North America held the second largest market share in 2017 owing to increasing prevalence of different digestive disorders • Some of the key companies operating in this market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy's Laboratories Ltd.; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.
Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of Tables
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Increasing Prevelance Of Gastro Esophageal Reflux Diseases (GERD)
5.1.2 Growing Geriatric Population
5.1.3 Increasing Prevalence Of Heartburn
5.2 Market Restraint Analysis
5.2.1 Growing Number Of Alternatives In The Market For Antacids
Chapter 6 Business Environment Analysis
6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter's Five Forces Analysis
Chapter 7 Dosage Form Business Analysis
7.1 Antacid Market: Dosage Form Movement Analysis
7.2 Tablet
7.2.1 Tablet Market Estimates And Forecast, 2014 - 2025
7.3 Liquid
7.3.1 Liquid Market Estimates And Forecast, 2014 - 2025
7.4 Others
7.4.1 Others Market Estimates And Forecast, 2014 - 2025
Chapter 8 Distribution Channel Business Analysis
8.1 Antacid Market: Distribution Channel Movement Analysis
8.2 Retail Pharmacy
8.2.1 Retail Pharmacy Market Estimates And Forecast, 2014 - 2025
8.3 Hospital Pharmacy
8.3.1 Hospital Pharmacy Market Estimates And Forecast, 2014 - 2025
8.4 Online Pharmacy
8.4.1 Online Pharmcay Market Estimates And Forecast, 2014 - 2025
Chapter 9 Regional Business Analysis
9.1 Antacid Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Market Estimates And Forecast, 2014 - 2025
9.2.2 U.S.
9.2.2.1 U.S. Market Estimates And Forecast, 2014 - 2025
9.2.3 Canada
9.2.3.1 Canada Market Estimates And Forecast, 2014 - 2025
9.3 Europe
9.3.1 Europe Market Estimates And Forecast, 2014 - 2025
9.3.2 Germany
9.3.3 Germany Market Estimates And Forecast, 2014 - 2025
9.3.4 U.K.
9.3.5 U.K. Market Estimates And Forecast, 2014 - 2025
9.4 Asia-Pacific
9.4.1 Asia-Pacific Market Estimates And Forecast, 2014 - 2025
9.4.2 Japan
9.4.2.1 Japan Market Estimates And Forecast, 2014 - 2025
9.4.3 China
9.4.3.1 China Market Estimates And Forecast, 2014 - 2025
9.4.4 India
9.4.4.1 India Market Estimates And Forecast, 2014 - 2025
9.5 Latin America
9.5.1 Latin America Market Estimates And Forecast, 2014 - 2025
9.5.2 Brazil
9.5.2.1 Brazil Market Estimates And Forecast, 2014 - 2025
9.5.3 Mexico
9.5.3.1 Market Estimates And Forecast, 2014 - 2025
9.6 Middle East And Africa
9.6.1 Middle-East And Africa Market Estimates And Forecast, 2014 - 2025
9.6.2 South Africa
9.6.3 South Africa Market Estimates And Forecast, 2014 - 2025
Chapter 10 Company Profiles
10.1 Company Profiles
10.1.1 GlaxoSmithkline plc.
10.1.1.1 Company Overview
10.1.1.2 Financial Performance
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Bayer AG
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Pfizer, Inc.
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.4 Boehringer Ingelheim International GmbH
10.1.4.1 Company Overview
10.1.4.2 Product Benchmarking
10.1.4.3 Strategic Initiatives
10.1.5 Dr. Reddy's Laboratories Ltd.
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.6 Reckitt Benckiser Group plc.
10.1.6.1 Company Overview
10.1.6.2 Financial Performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Sanofi
10.1.7.1 Company Overview
10.1.7.2 Product Benchmarking
10.1.7.3 Strategic Initiatives
10.1.8 Sun Pharmaceuticals Ltd.
10.1.8.1 Company Overview
10.1.8.2 Financial Performance
10.1.8.3 Product Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Takeda Pharmaceutical Company Limited
10.1.9.1 Company Overview
10.1.9.2 Product Benchmarking
10.1.9.3 Strategic Initiatives
10.1.10 Procter & Gamble
10.1.10.1 Company Overview
10.1.10.2 Product Benchmarking
10.1.10.3 Strategic Initiatives
List of Tables Table 1 List of Abbreviation Table 2 North America Antacid market, by dosage form 2014 - 2025 (USD Million) Table 3 North America Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 4 U.S. Antacid market, by dosage form 2014 - 2025 (USD Million) Table 5 U.S. Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 6 Canada Antacid market, by dosage form 2014 - 2025 (USD Million) Table 7 Canada Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 8 Europe Antacidmarket, by dosage form 2014 - 2025 (USD Million) Table 9 Europe Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 10 Germany Antacid market, by dosage form 2014 - 2025 (USD Million) Table 11 Germany Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 12 U.K. Antacid market, by dosage form 2014 - 2025 (USD Million) Table 13 U.K. Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 14 Asia Pacific Antacid market, by dosage form 2014 - 2025 (USD Million) Table 15 Asia Pacific Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 16 Japan Antacid market, by dosage form 2014 - 2025 (USD Million) Table 17 Japan Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 18 China Antacid market, by dosage form 2014 - 2025 (USD Million) Table 19 China Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 20 India Antacidmarket, by dosage form 2014 - 2025 (USD Million) Table 21 India Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 22 Latin America Antacidmarket, by dosage form 2014 - 2025 (USD Million) Table 23 Latin America Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 24 Brazil Antacid market, by dosage form 2014 - 2025 (USD Million) Table 25 Brazil Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 26 Mexico Antacid market, by dosage form 2014 - 2025 (USD Million) Table 27 Mexico Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 28 MEA Antacid market, by dosage form 2014 - 2025 (USD Million) Table 29 MEA Antacid market, by distribution channel 2014 - 2025 (USD Million) Table 30 South Africa Antacid market, by dosage form 2014 - 2025 (USD Million) Table 31 South Africa Antacid market, by distribution channel 2014 - 2025 (USD Million)
List of Figures Fig. 1 Antacidmarket, 2017 Fig. 2 Antacid market segmentation Fig. 3 Antacid market driver impact Fig. 4 Antacid market driver impact Fig. 5 SWOT Analysis, By Factor (Political & legal economic and technological) Fig. 6 Porter's Five Forces Analysis Fig. 6 Antacid market: Dosage form outlook and key takeaways Fig. 7 Antacid market: Dosage Form Movement Analysis Fig. 8 Tablet market estimates and forecast, 2014 - 2025 Fig. 9 Liquid market estimates and forecast, 2014 - 2025 Fig. 10 Others market estimates and forecast, 2014 - 2025 Fig. 11 Antacid market: Distribution channel outlook and key takeaways Fig. 12 Antacid market: Distribution Channel Movement Analysis Fig. 13 Retail pharmacy market estimates and forecast, 2014 - 2025 Fig. 14 Hospital pharmacy market estimates and forecast, 2014 - 2025 Fig. 15 Online pharmacy market estimates and forecast, 2014 - 2025 Fig. 16 Antacid market: Regional outlook and key takeaways Fig. 17 Antacid market: Regional movement analysis Fig. 18 North America Fig. 19 North America. market estimates and forecast, 2014 - 2025 Fig. 20 U.S. market estimates and forecast, 2014 - 2025 Fig. 21 Canada market estimates and forecast, 2014 - 2025 Fig. 22 Europe Fig. 23 Europe market estimates and forecast, 2014 - 2025 Fig. 24 Germany market estimates and forecast, 2014 - 2025 Fig. 25 U.K. market estimates and forecast, 2014 - 2025 Fig. 26 Asia-Pacific Fig. 27 Asia-Pacific market estimates and forecast, 2014 - 2025 Fig. 28 Japan market estimates and forecast, 2014 - 2025 Fig. 29 China market estimates and forecast, 2014 - 2025 Fig. 30 India market estimates and forecast, 2014 - 2025 Fig. 31 Latin America Fig. 32 Latin America market estimates and forecast, 2014 - 2025 Fig. 33 Brazil market estimates and forecast, 2014 - 2025 Fig. 34 Mexico market estimates and forecast, 2014 - 2025 Fig. 35 Middle East & Africa Fig. 36 MEA market estimates and forecast, 2014 - 2025 Fig. 37 South Africa market estimates and forecast, 2014 - 2025 Fig. 38 Company profile
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
